Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

Fig. 3

Radiographic progression for patients cross-classified by conventional disease activity measures and adjusted MBDA score. Percentages of patients with progression are shown for patients with low, moderate, and high MBDA scores within the indicated categories of 28-joint disease activity score with CRP (DAS28-CRP) (a), C-reactive protein (b), 28 swollen joint count (SJC) (c), and Clinical Disease Activity Index (CDAI) (d). Categories were determined at the time of the first radiograph for each patient. NP no patients. Radiographic progression was defined as change in van der Heijde-modified Sharp score (ΔTSS) > 5 units per year. MBDA multi-biomarker disease activity

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us